JonesTrading Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $7

Futu NewsDec 30, 2024 22:31 · Ratings

Chimerix Announces NDA Submission For Dordaviprone - Quick Facts

RTTNewsDec 30, 2024 20:28

Express News | Chimerix Inc - Enters Credit Facility of up to $30 Million With Svb

BreakingsDec 30, 2024 20:04

Chimerix Seeks FDA Approval for New Drug Targeting Deadly Brain Cancer

BenzingaDec 30, 2024 20:01

Express News | Chimerix Inc - Requests Priority Review for Nda

BreakingsDec 30, 2024 20:01

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients With Recurrent H3 K27M-Mutant Diffuse Glioma

ChimerixDec 30, 2024 13:00